The story of Wockhardt Yellow is a sobering reminder concerning the vulnerability of pharmaceutical integrity. What started as a seemingly benign yellow coloring in medication quickly transformed into a grave crisis, revealing serious shortcomings in the manufacturing and quality regulation. This profound tale serves the crucial need for robust reg